SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Amarin Corporation PLC Announces Notification of Additional U.S. Patent Allowance for U.S. Application 13/272,520 Based on ANCHOR Clinical Trial Results